In 2017, the notification rate of tuberculosis in the Northern Region of Portugal was 21.1 cases per 100 000 inhabitants. According to the National Tuberculosis Programme Surveillance System (SVIG-TB), poly-resistance to isoniazid and streptomycin (PR-HS) represented 2.6–5% of the cases notified in the Northern Region between 2009 and 2017 Although they represent a relatively low proportion of cases in Portugal, poly-resistances such as PR-HS are precursors to multidrug resistance and, consequently, should be closely monitored
Letters to the EditorExtract: The occurrence of multidrug and extensively drug-resistant tuberculosi...
SUMMARYIn 1995 the Microbiology Department of Hospital de Curry Cabral started systematic drug susce...
Emergence of extensively drug-resistant tuberculosis (XDR-TB) represents an enormous challenge to Pu...
In Western Europe, Portugal has the highest incidence of tuberculosis (TB) as well as HIV infection....
AbstractMultidrug-resistance and extensive drug-resistance pose a serious threat to tuberculosis man...
AbstractTuberculosis (TB) was explicitly recognized as a major global public health problem in the e...
ABSTRACTBACKGROUND: A network for the Surveillance of Antituberculosis Drug Resistance (VigLab-Tuber...
Monitoring the extent of and trends in multidrug-resistant tuberculosis (MDR-TB) is a priority of th...
Portugal has the fourth highest tuberculosis (TB) incidence rate in the European Union (EU). Thirty-...
An increase in the number of new cases of tuberculosis (TB) combined with poor clinical outcome was ...
Monitoring the extent of and trends in multidrug-resistant tuberculosis (MDR-TB) is a priority of th...
Increasing multidrug-resistant tuberculosis (MDR-TB) incidence is a major threat against TB eradicat...
Background Tuberculosis (TB) incidence declined in Portugal in recent decades, but trends differ bet...
Tuberculosis (TB) is a global public health concern. Surveillance programmes present invaluable epid...
This paper describes the results of second-line drug (SLD) susceptibility tests among multidrug-resi...
Letters to the EditorExtract: The occurrence of multidrug and extensively drug-resistant tuberculosi...
SUMMARYIn 1995 the Microbiology Department of Hospital de Curry Cabral started systematic drug susce...
Emergence of extensively drug-resistant tuberculosis (XDR-TB) represents an enormous challenge to Pu...
In Western Europe, Portugal has the highest incidence of tuberculosis (TB) as well as HIV infection....
AbstractMultidrug-resistance and extensive drug-resistance pose a serious threat to tuberculosis man...
AbstractTuberculosis (TB) was explicitly recognized as a major global public health problem in the e...
ABSTRACTBACKGROUND: A network for the Surveillance of Antituberculosis Drug Resistance (VigLab-Tuber...
Monitoring the extent of and trends in multidrug-resistant tuberculosis (MDR-TB) is a priority of th...
Portugal has the fourth highest tuberculosis (TB) incidence rate in the European Union (EU). Thirty-...
An increase in the number of new cases of tuberculosis (TB) combined with poor clinical outcome was ...
Monitoring the extent of and trends in multidrug-resistant tuberculosis (MDR-TB) is a priority of th...
Increasing multidrug-resistant tuberculosis (MDR-TB) incidence is a major threat against TB eradicat...
Background Tuberculosis (TB) incidence declined in Portugal in recent decades, but trends differ bet...
Tuberculosis (TB) is a global public health concern. Surveillance programmes present invaluable epid...
This paper describes the results of second-line drug (SLD) susceptibility tests among multidrug-resi...
Letters to the EditorExtract: The occurrence of multidrug and extensively drug-resistant tuberculosi...
SUMMARYIn 1995 the Microbiology Department of Hospital de Curry Cabral started systematic drug susce...
Emergence of extensively drug-resistant tuberculosis (XDR-TB) represents an enormous challenge to Pu...